Generic Cholesterol-Fighting Drug Hits the Market
Posted by Howard Kettner on Dec 19, 2011 in Drugs & Medication, Featured, Group Employee Benefits | 0 comments
Generic alternatives have been gaining a lot of attention; especially with their potential to significantly reduce drug costs for group benefit plans. Earlier this month a generic version of a cholesterol fighting drug called Lipitor was introduced. In the first few days that it was available, the generic alternative captured 14% of the prescription volume for Lipitor. Some researchers are predicting that the generic drug will hold 44% of the market by 2014.
As more and more popular brand-name drugs come off patent, it will be interesting to see the effect of generic alternatives on the market for brand-name drugs.